INFACOL

This brand name is authorized in Canada, Cyprus, Hong Kong, Malta, Poland, United Kingdom

Active ingredients

The drug INFACOL contains one active pharmaceutical ingredient (API):

1 Simethicone UNII 92RU3N3Y1O - DIMETHICONE

Simethicone is a chemically inert, non-systemic gastric defoaming agent that works by altering the elasticity of interfaces of mucus-embedded bubbles in the gastrointestinal tract. The gas bubbles are thus broken down or coalesced and in this form gas is more easily eliminated through eructation or passing flatus. Read about Simethicone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INFACOL Oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A03AX13	Silicones	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AX Other drugs for functional bowel disorders
Discover more medicines within A03AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02248588
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 368428, 368429
Country: HK	Department of Health Drug Office	Identifier(s): 21432
Country: MT	Medicines Authority	Identifier(s): AA908/06901
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094601, 100417620